TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

HAMELN RDS GMBH

Pharmaceuticals
Generics

HAMELN RDS GMBH is a generic drug manufacturer with 1 FDA-approved products.

2012
Since
1
Drugs
-
Trials
24
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

GEMCITABINE HYDROCHLORIDE 2025-09-16
Labeling
GEMCITABINE HYDROCHLORIDE 2025-08-04
Labeling
GEMCITABINE HYDROCHLORIDE 2025-08-04
Labeling
GEMCITABINE HYDROCHLORIDE 2025-07-24
Labeling
GEMCITABINE HYDROCHLORIDE 2025-07-09
Labeling
GEMCITABINE HYDROCHLORIDE 2024-09-24
Labeling
GEMCITABINE HYDROCHLORIDE 2024-09-24
Labeling
GEMCITABINE HYDROCHLORIDE 2024-09-24
Labeling
GEMCITABINE HYDROCHLORIDE 2024-09-24
Labeling
GEMCITABINE HYDROCHLORIDE 2024-09-24
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Strength Pro

Loading...